drugset / Trial / NCT05833035
A Study in Healthy Men to Test How BI 1291583 is Processed in the Body
NaSingle-groupOpen-labelTreatment
Summary
The main objective of this trial is to * Assess the mass balance and total recovery of \[14C\]-radioactivity in urine and faeces following a dose of BI 1291583 (C-14) * Provide plasma and urine samples for pharmacokinetic investigations * Provide plasma, urine, and faeces samples for metabolic profiling and structural identification of metabolites
Timeline
- Start
- 2023-04-24
- Primary completion
- 2023-07-05
- Completion
- 2023-07-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BI 1291583 | Unknown | — | Oral |
Indications
No indication recorded.